Back
Apellis Pharmaceuticals Vs. Agilysys Industry Stock Comparison
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$18.62
Seasonality Move:
-9.52%
Buy
79
AGYS
Agilysys
Last Price:
$115.15
Seasonality Move:
3.68%
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.62. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.62The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 42.42 | Sell |
Chaikin Money Flow: | 648223 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.32 - 19.04) | Sell |
Bollinger Bands (100): | (17.64 - 26.36) | Sell |
AGYS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.37 | Buy |
Relative Strength Index (14 RSI): | 70.81 | Buy |
Chaikin Money Flow: | 306363 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.9 - 113.76) | Buy |
Bollinger Bands (100): | (71.02 - 99.1) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.31 | Sell |
20-day SMA: | 18.29 | Sell |
50-day SMA: | 18.23 | Sell |
200-day SMA: | 26.72 | Sell |
8-day EMA: | 18.11 | Sell |
20-day EMA: | 18.29 | Sell |
50-day EMA: | 19.17 | Sell |
200-day EMA: | 26.88 | Sell |
AGYS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.18 | Buy |
20-day SMA: | 109.25 | Buy |
50-day SMA: | 90.53 | Buy |
200-day SMA: | 101.93 | Buy |
8-day EMA: | 110.23 | Buy |
20-day EMA: | 106.6 | Buy |
50-day EMA: | 97.03 | Buy |
200-day EMA: | 95.99 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
Agilysys Earnings Growth & AGYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.25 per share, and an increase next year of $0.34 per share.
Apellis Pharmaceuticals Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agilysys Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |